Digestive Diseases and Sciences

, Volume 48, Issue 11, pp 2159–2166 | Cite as

Differential Action of Growth Hormone in Irradiated Tumoral and Nontumoral Intestinal Tissue

  • Juana Morante
  • María T. Vallejo-Cremades
  • Lourdes Gómez-García
  • Isabel Vázquez
  • Ignacio A. Gómez-De-Segura
  • Miriam Sanchez
  • Enrique De MiguelEmail author


Growth hormone (GH) protects the intestines from antitumoral therapy, but it is not known whether or not the tumor is also protected in vivo. The aim of the present work was to determine whether GH administration modifies the response by a colonic adenocarcinoma to radiation in vitro and in vivo. BDIX rats were implanted with a colonic adenocarcinoma and two weeks later GH treatment was started. Animals were then irradiated, and four days later samples from the intestines and tumor were taken for analysis. In vitro assays were performed in parallel to confirm the effects observed in vivo. GH reduced radiation-induced intestinal injury by improving proliferation and reducing apoptosis and p53 expression. However, tumor proliferation was reduced by GH while apoptosis and p53 expression remained unchanged. A similar response was observed in vitro. Thus, GH administration before radiotherapy protects the intestines but not the implanted adenocarcinoma in the rat.

growth hormone cancer adenocarcinoma radiotherapy intestines rats 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vazquez I, Gomez de Segura IA, Grande AG, Escribano A, Gonzalez-Gancedo P, Gomez A, Diez R, De-Miguel E: Protective effect of enriched diet plus growth hormone administration on radiation-induced intestinal injury and on its evolutionary pattern in the rat. Dig Dis Sci 44:2350-2358, 1999Google Scholar
  2. 2.
    Gomez de Segura IA, Prieto I, Grande AG, Garcia P, Guerra A, Mendez J, De-Miguel E: Growth hormone reduces mortality and bacterial translocation in irradiated rats. Acta Oncol 37:179-185, 1998Google Scholar
  3. 3.
    Pierce GF, Yanagihara D, Klopchin K, Danilenko DM, Hsu E, Kenney WC, Morris CF: Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor. J Exp Med 179:831-840, 1994Google Scholar
  4. 4.
    Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, Havill AM, Lu ZN, Auxerman SL, Pierce, GF, Thomason A, Potten CS, Ulich TR, Lacey DL: Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58:933-939, 1998Google Scholar
  5. 5.
    Booth D, Potten CS: Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr 29:16-20, 2001Google Scholar
  6. 6.
    Weinert T. DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell 94:555-558, 1998Google Scholar
  7. 7.
    Wilson JW, Pritchard DM, Hickman JA, Potten CS: Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intestinal epithelium: apoptosis and cell cycle arrest. Am J Pathol 153:899-909, 1998Google Scholar
  8. 8.
    Marijnen CA, Kapiteijn E, Nagtegaal ID, Mulder S, van d, Schrier PI, Peltenburg LT, van K: p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas. Int J Radiat Oncol Biol Phys 52:720-728, 2002Google Scholar
  9. 9.
    Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, Kolesnick R: Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293:293-297, 2001Google Scholar
  10. 10.
    Mylonas PG, Matsouka PT, Papandoniou EV, Vagianos C, Kalfarentzos F, Alexandrides TK: Growth hormone and insulin-like growth factor I protect intestinal cells from radiation induced apoptosis. Mol Cell Endocrinol 160:115-122, 2000Google Scholar
  11. 11.
    Howarth GS, Cool JC, Bourne AJ, Ballard FJ, Read LC: Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate. Growth Factors 15:279-292, 1998Google Scholar
  12. 12.
    Bartlett DL, Stein P, Torosian MH: Effect of growth hormone and protein intake on tumor growth and host cachexia. Surgery 117:260-267, 1995Google Scholar
  13. 13.
    Fiebig HH, Dengler W, Hendriks HR: No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone. Anticancer Drugs 11:659-664, 2000Google Scholar
  14. 14.
    Wolf RF, Ng B, Weksler B, Burt M, Brennan MF: Effect of growth hormone on tumor and host in an animal model. Ann Surg Oncol 1:314-320, 1994Google Scholar
  15. 15.
    Okunieff P, Li M, Liu W, Sun J, Fenton B, Zhang L, Ding I: Keratinocyte growth factors radioprotect bowel and bone marrow but not KHT sarcoma. Am J Clin Oncol 24:491-495, 2001Google Scholar
  16. 16.
    Harrison LE, Blumberg D, Berman R, Ng B, Hochwald S, Brennan MF, Burt M: Effect of human growth hormone on human pancreatic carcinoma growth, protein, and cell cycle kinetics. J Surg Res 61:317-322, 1996Google Scholar
  17. 17.
    Donoway RB, Torosian MH: Growth hormone inhibits tumor metastases. Surg Forum 40:413-415, 1989Google Scholar
  18. 18.
    Blanck A, Assefaw-Redda Y, Eriksson LC, Gustafsson JA, Ekvarn S, Hallstrom IP: Growth hormone administration after treatment in the resistant hepatocyte model does not affect progression of rat liver carcinogenesis. Cancer Lett 79:193-198, 1994Google Scholar
  19. 19.
    Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752-755, 1989Google Scholar
  20. 20.
    Khan WB, Shui C, Ning S, Knox SJ: Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res 148:248-253, 1997Google Scholar
  21. 21.
    Ning S, Shui C, Khan WB, Benson W, Lacey DL, Knox SJ: Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo. Int J Radiat Oncol Biol Phys 40:177-187, 1998Google Scholar
  22. 22.
    Binnerts A, Uittterlinden P, Hofland LJ, van-Koetsveld P, Lamberts SW: The in vitro and in vivo effects of human growth hormone administration on tumor growth of rats bearing a transplantable rat pituitary tumor (7315b). Eur J Cancer 26:269-276, 1990Google Scholar
  23. 23.
    Giesbert S, Panzer S, Kovar H, Fischer S, Printz D, Gadner H, Panzer-Grumayer ER: Acute leukemias express a functional receptor for the human growth hormone. Ann Hematol 74:253-257, 1997Google Scholar
  24. 24.
    Madrid O, Varea S, Sánchez-Pérez I, Gomez-García L, De Miguel E, Gomez de Segura IA, Perona R: Growth hormone protects against radiotherapy induced cell death. Eur J Endocrinol 147:535-541, 2002Google Scholar
  25. 25.
    el Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993Google Scholar
  26. 26.
    Smith ML, Fornace AJ: p53-mediated protective responses to UV irradiation. Proc Natl Acad Sci USA 94:12255-12257, 1997Google Scholar

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  • Juana Morante
    • 1
  • María T. Vallejo-Cremades
    • 1
  • Lourdes Gómez-García
    • 1
  • Isabel Vázquez
    • 1
  • Ignacio A. Gómez-De-Segura
    • 1
  • Miriam Sanchez
    • 1
  • Enrique De Miguel
    • 1
    Email author
  1. 1.Research UnitThe La Paz University HospitalMadridSpain

Personalised recommendations